Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data
dc.contributor.author | Soyer, N. | |
dc.contributor.author | Ali, R. | |
dc.contributor.author | Turgut, M. | |
dc.contributor.author | Haznedaroglu, I. | |
dc.contributor.author | Yilmaz, F. | |
dc.contributor.author | Aydogdu, I. | |
dc.contributor.author | Ceran, F. | |
dc.date.accessioned | 2021-05-03T20:41:32Z | |
dc.date.available | 2021-05-03T20:41:32Z | |
dc.date.issued | 2018 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | 9th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 17-20, 2018 -- Istanbul, TURKEY | en_US |
dc.description | comert, melda/0000-0002-7798-4349; Karakus, Volkan/0000-0001-9178-2850; Haznedaroglu, Ibrahim C./0000-0001-8028-9462 | en_US |
dc.description.abstract | [No Abstract Available] | en_US |
dc.identifier.endpage | S46 | en_US |
dc.identifier.issn | 0145-2126 | |
dc.identifier.issn | 1873-5835 | |
dc.identifier.startpage | S46 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/70595 | |
dc.identifier.volume | 73 | en_US |
dc.identifier.wos | WOS:000447176600107 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.relation.ispartof | Leukemia Research | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data | en_US |
dc.type | Conference Object | en_US |